| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.8M | -33.3% |
| R&D Expense | $117.7M | -0.1% |
| SG&A Expense | $42.1M | -1.7% |
| Operating Income | -$139.0M | -7.3% |
| Pre-tax Income | -$131.2M | -2.4% |
| Income Tax | $1.3M | — |
| Net Income | -$132.5M | -3.4% |
| EPS (Basic) | -$2.67 | -1.9% |
| EPS (Diluted) | -$2.67 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $126.6M | +325.5% |
| Accounts Receivable | $11.8M | +701.0% |
| Current Assets | $271.2M | -5.7% |
| Total Assets | $376.5M | -12.6% |
| Current Liabilities | $42.8M | -4.0% |
| Long-term Debt | $11.5M | +0.0% |
| Total Liabilities | $130.3M | -8.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.8M | -0.8% |
| Capital Expenditures | $1.7M | -68.9% |
| Investing Cash Flow | $158.3M | +171.0% |
| Financing Cash Flow | $45.5M | +3865.9% |
| Free Cash Flow | -$108.5M | +2.6% |
| -1.9% |
| Stockholders' Equity |
| $246.1M |
| -14.9% |